GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,646.80p
   
  • Change Today:
    -12.60p
  • 52 Week High: 2,263.00
  • 52 Week Low: 1,635.40
  • Currency: UK Pounds
  • Shares Issued: 4,067.35m
  • Volume: 6,615,609
  • Market Cap: 66,981m
  • RiskGrade: 129

GSK Overview

UK-based GSK Plc is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

GSK Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 30,186.00 3,525.00 111.80p 14.8 1.6 +9% 80.00p 4.8%
31-Dec-18 30,821.00 4,800.00 119.40p 15.6 2.2 +7% 80.00p 4.3%
31-Dec-19 33,754.00 6,221.00 123.90p 17.9 4.5 +4% 80.00p 3.6%
31-Dec-20 34,099.00 6,968.00 1.17p 1,433.9 n/a -99% 0.81p 0.0%
31-Dec-21 34,114.00 5,442.00 113.20p 17.7 0.0 +9,576% 80.00p 4.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GSK Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 28,862.80 6,752.17 124.23p 13.3 1.4 +10% 56.74p 3.4%
31-Dec-23 29,317.03 7,441.12 134.68p 12.2 1.5 +8% 55.60p 3.3%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

GSK Company Announcements

Total Voting Rights 01-Aug-2022 18:10 RNS
Director/PDMR Shareholding 01-Aug-2022 13:43 RNS
Director/PDMR Shareholding 29-Jul-2022 14:00 RNS

Latest GSK Director Deals

Traded Action Notifier PriceAmountValue
27-Jul-22 Sell Emma Walmsley 1,763.41p 148,525 2,619,104.70
27-Jul-22 Transfer From Emma Walmsley 0.000p 307,823 0.00
22-Jul-22 Buy Hal Barron 1,761.17p 2,436 42,902.18

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GSK Market Data

Currency UK Pounds
Share Price 1,646.80p
Change Today -12.60p
% Change -0.76 %
52 Week High 2,263.00
52 Week Low 1,635.40
Volume 6,615,609
Shares Issued 4,067.35m
Market Cap 66,981m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
34.28% below the market average34.28% below the market average34.28% below the market average34.28% below the market average34.28% below the market average
37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 7
Buy 1
Neutral 13
Sell 0
Strong Sell 1
Total 22
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q2 Q1
Ex-Div 18-Aug-22 19-May-22
Paid 06-Oct-22 01-Jul-22
Amount 16.25p 14.00p

Trades for 09-Aug-2022

Time Volume / Share Price
16:38 231,820 @ 1,645.86p
17:02 334 @ 1,651.72p
17:02 334 @ 1,652.05p
16:45 8,314 @ 1,646.40p
16:45 8,314 @ 1,646.40p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page